Skip to main content
. 2021 Jan 4;5(5):e000885. doi: 10.1136/esmoopen-2020-000885

Figure 2.

Figure 2

Proportions of IgM and/or IgG-positive (IgM and/or IgG+) and IgM and IgG-negative (IgM and IgG-) COVID-19 rapid serological test results according to cancer type (A) and treatment administered (B). mAb, monoclonal antibody; GI, gastrointestinal; HT, hormonotherapy.